Stilbenes and fenamates rescue the loss of IKS channel function induced by an LQT5 mutation and other IsK mutants

Genetic and physiological studies have established a link between potassium channel dysfunction and a number of neurological and muscular disorders. Many ‘channelopathies’ are accounted for by a dominant‐lethal suppression of potassium channel function. In the cardiac IKS channel complex comprising the α and β subunits, KvLQT1 and IsK, respectively, several mutations lead to a dominant‐negative loss of channel function. These defects are responsible for a human cardiovascular disease called long QT (LQT) syndrome. Here we show that binding of IKS channel activators, such as stilbenes and fenamates, to an extracellular domain flanking the human IsK transmembrane segment, restores normal IKS channel gating in otherwise inactive IsK C‐terminal mutants, including the naturally occurring LQT5 mutant, D76N. Our data support a model in which allosteric interactions exist between the extracellular and intracellular boundaries of the IsK transmembrane segment as well as between domains of the α and β subunits. Disruption of this allosteric interplay impedes slow activation gating, decreases current amplitude and restores channel inactivation. Owing to allosteric interactions, stilbene and fenamate compounds can rescue the dominant‐negative suppression of IKS produced by IsK mutations and thus, may have important therapeutic relevance for LQT syndrome.

[1]  Thomas Friedrich,et al.  KCNQ4, a Novel Potassium Channel Expressed in Sensory Outer Hair Cells, Is Mutated in Dominant Deafness , 1999, Cell.

[2]  R. Kass,et al.  MinK-KvLQT1 Fusion Proteins, Evidence for Multiple Stoichiometries of the Assembled I sK Channel* , 1998, The Journal of Biological Chemistry.

[3]  M. Pusch Increase of the single-channel conductance of KvLQT1 potassium channels induced by the association with minK , 1998, Pflügers Archiv.

[4]  F. Sesti,et al.  Single-Channel Characteristics of Wild-Type IKs Channels and Channels formed with Two MinK Mutants that Cause Long QT Syndrome , 1998, The Journal of general physiology.

[5]  Fred J. Sigworth,et al.  Single-Channel Properties of IKs Potassium Channels , 1998, The Journal of general physiology.

[6]  F. Conti,et al.  Activation and inactivation of homomeric KvLQT1 potassium channels. , 1998, Biophysical journal.

[7]  M. Sanguinetti,et al.  Voltage‐dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits , 1998, The Journal of physiology.

[8]  M. Lazdunski,et al.  IKs, a slow and intriguing cardiac K+ channel and its associated long QT diseases. , 1998, Trends in cardiovascular medicine.

[9]  B. Chait,et al.  The structure of the potassium channel: molecular basis of K+ conduction and selectivity. , 1998, Science.

[10]  S. Goldstein,et al.  The conduction pore of a cardiac potassium channel , 1998, Nature.

[11]  Priya D. Duggal,et al.  Mutation of the gene for IsK associated with both Jervell and Lange-Nielsen and Romano-Ward forms of Long-QT syndrome. , 1998, Circulation.

[12]  S. Berkovic,et al.  A potassium channel mutation in neonatal human epilepsy. , 1998, Science.

[13]  Mark Leppert,et al.  A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns , 1998, Nature Genetics.

[14]  Robin J. Leach,et al.  A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family , 1998, Nature Genetics.

[15]  M. Sanguinetti,et al.  Mutations in the hminK gene cause long QT syndrome and suppress lKs function , 1997, Nature Genetics.

[16]  G. Breithardt,et al.  KCNE1 mutations cause Jervell and Lange-Nielsen syndrome , 1997, Nature Genetics.

[17]  M. Pembrey,et al.  IsK and KvLQT1: mutation in either of the two subunits of the slow component of the delayed rectifier potassium channel can cause Jervell and Lange-Nielsen syndrome. , 1997, Human molecular genetics.

[18]  B. Wollnik,et al.  Pathophysiological Mechanisms of Dominant and Recessive Kvlqt1 K + Channel Mutations Found in Inherited Cardiac Arrhythmias , 1997 .

[19]  M. Lazdunski,et al.  Properties of KvLQT1 K+ channel mutations in Romano–Ward and Jervell and Lange‐Nielsen inherited cardiac arrhythmias , 1997, The EMBO journal.

[20]  W. Stühmer,et al.  The role of the IsK protein in the specific pharmacological properties of the IKs channel complex , 1997, British journal of pharmacology.

[21]  B Attali,et al.  Molecular Mechanism and Functional Significance of the MinK Control of the KvLQT1 Channel Activity* , 1997, The Journal of Biological Chemistry.

[22]  L. Kaczmarek,et al.  Properties and regulation of the minK potassium channel protein. , 1997, Physiological reviews.

[23]  M. Keating,et al.  Molecular basis of the long-QT syndrome associated with deafness. , 1997, The New England journal of medicine.

[24]  D. Clapham,et al.  Ion channels--basic science and clinical disease. , 1997, The New England journal of medicine.

[25]  P. Coumel,et al.  A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome , 1997, Nature Genetics.

[26]  A. Busch,et al.  Role of the ISK protein in the IminK channel complex. , 1997, Trends in pharmacological sciences.

[27]  S. Heinemann,et al.  Inner Ear Defects Induced by Null Mutationof the isk Gene , 1996, Neuron.

[28]  Jacques Barhanin,et al.  KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.

[29]  B. Attali A new wave for heart rhythms , 1996, Nature.

[30]  F. Collins,et al.  KVLQT1 mutations in three families with familial or sporadic long QT syndrome. , 1996, Human molecular genetics.

[31]  B. Attali,et al.  Cytoplasmic and Extracellular IsK Peptides Activate Endogenous K and Cl Channels in Xenopus Oocytes , 1996, The Journal of Biological Chemistry.

[32]  S. Goldstein,et al.  MinK Residues Line a Potassium Channel Pore , 1996, Neuron.

[33]  M. Sanguinetti,et al.  Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. , 1996, Nature.

[34]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[35]  S. Goldstein,et al.  Subunit composition of mink potassium channels , 1995, Neuron.

[36]  H. Maldonado,et al.  Labeling of the Amphiuma erythrocyte K+/H+ exchanger with H2DIDS. , 1994, The American journal of physiology.

[37]  F. Lang,et al.  Positive regulation by chloride channel blockers of IsK channels expressed in Xenopus oocytes. , 1994, Molecular pharmacology.

[38]  D. C. Marcus,et al.  Slowly activating voltage-dependent K+ conductance is apical pathway for K+ secretion in vestibular dark cells. , 1994, The American journal of physiology.

[39]  M. Lazdunski,et al.  The protein IsK is a dual activator of K+ and CI− channels , 1993, Nature.

[40]  B Attali,et al.  Are Xenopus oocytes unique in displaying functional IsK channel heterologous expression? , 1993, Receptors & channels.

[41]  S. Nakanishi,et al.  Alteration of channel activities and gating by mutations of slow ISK potassium channel. , 1991, The Journal of biological chemistry.

[42]  M. Sanguinetti,et al.  Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents , 1990, The Journal of general physiology.

[43]  H. Lodish,et al.  Cloning and characterization of band 3, the human erythrocyte anion-exchange protein (AE1). , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Nakanishi,et al.  Cloning of a membrane protein that induces a slow voltage-gated potassium current. , 1988, Science.

[45]  A. G. Lowe,et al.  Chloride/bicarbonate exchange in human erythrocytes. , 1978, The Journal of physiology.

[46]  D. Noble,et al.  Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres , 1969, The Journal of physiology.